BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 11396122)

  • 1. [Performance of Slovak hospitals as related to Porter's generic strategies].
    Hlavacka S; Bacharova L; Rusnakova V; Wagner R
    Bratisl Lek Listy; 2001; 102(2):106-14. PubMed ID: 11396122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Performance implications of Porter's generic strategies in Slovak hospitals.
    Hlavacka S; Bacharova L; Rusnakova V; Wagner R
    J Manag Med; 2001; 15(1):44-66. PubMed ID: 11407185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pure versus hybrid: performance implications of Porter's generic strategies.
    Kumar K; Subramanian R; Yauger C
    Health Care Manage Rev; 1997; 22(4):47-60. PubMed ID: 9358260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of Porter's generic strategies in ambulatory health care: a comparison of managerial perceptions in two Israeli sick funds.
    Torgovicky R; Goldberg A; Shvarts S; Bar Dayan Y; Onn E; Levi Y; BarDayan Y
    Health Care Manage Rev; 2005; 30(1):17-23. PubMed ID: 15773250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of Porter’s Five Forces Model and generic strategies for vascular surgery: should be stuck in the middle?
    Sumpio BE
    Vascular; 2013 Jun; 21(3):149-56. PubMed ID: 23518839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Porter's generic strategies, discontinuous environments, and performance: a longitudinal study of changing strategies in the hospital industry.
    Lamont BT; Marlin D; Hoffman JJ
    Health Serv Res; 1993 Dec; 28(5):623-40. PubMed ID: 8270424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contextual factors and business strategy choice: The case of us hospitals.
    Ghiasi A; Weech-Maldonado R; Zengul F; Puro N
    Health Serv Manage Res; 2023 May; 36(2):127-136. PubMed ID: 35848540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing the industry using Porter's five forces.
    Vet Rec; 2014 Jan; 174 Suppl 1():3-4. PubMed ID: 24470612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strategy-making capability and performance of Slovak acute hospitals.
    Simo J; Hlavacka S
    Bratisl Lek Listy; 2001; 102(2):99-105. PubMed ID: 11396131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Testing some major determinants for hospital innovation success.
    Caccia-Bava Mdo C; Guimaraes VC; Guimaraes T
    Int J Health Care Qual Assur; 2009; 22(5):454-70. PubMed ID: 19725367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of an industry in transition.
    Baliga BR; Johnson B
    Health Care Strateg Manage; 1986 Dec; 4(12):5-14. PubMed ID: 10301354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strategic considerations for provider sponsored organizations entering the risk-bearing Medicare market.
    Treash M; Thomson K
    Manag Care Q; 1997; 5(4):43-7. PubMed ID: 10175719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The association of strategic group and organizational culture with hospital performance in China.
    Xue D; Zhou P; Bundorf MK; Huang JX; Chang JL
    Health Care Manage Rev; 2013; 38(3):258-70. PubMed ID: 22872139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The economic role of the Emergency Department in the health care continuum: applying Michael Porter's five forces model to Emergency Medicine.
    Pines JM
    J Emerg Med; 2006 May; 30(4):447-53. PubMed ID: 16740464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An analysis of the strategies for public hospitals.
    Madorran-García C; de Val-Pardo I
    Health Serv Manage Res; 2006 Nov; 19(4):251-63. PubMed ID: 17132201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Japanese hospitals--culture and competition: a study of ten hospitals.
    Anbäcken O
    Int J Health Plann Manage; 1994; 9(1):87-101. PubMed ID: 10137135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Orthopaedic Surgery Under National Health Reform: An Analysis of Power, Process, Adaptation, and Leadership: AOA Critical Issues.
    Callahan CD; Adair D; Bozic KJ; Manning BT; Saleh JK; Saleh KJ
    J Bone Joint Surg Am; 2014 Jul; 96(13):e111. PubMed ID: 24990985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Competitive forces in the medical group industry: a stakeholder perspective.
    Blair JD; Buesseler JA
    Health Care Manage Rev; 1998; 23(2):7-27. PubMed ID: 9595307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How Do Upper Echelons Perceive Porter's Five Forces? Evidence From Strategic Entrepreneurship in China.
    Shi C; Agbaku CA; Zhang F
    Front Psychol; 2021; 12():649574. PubMed ID: 34938221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Examination of nursing home financial distress via Porter's five competitive forces framework.
    Lord J; Weech-Maldonado R; Blackburn J; Carroll N
    Health Care Manage Rev; 2021 Jul-Sep 01; 46(3):E50-E60. PubMed ID: 33181555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.